Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MDU Resources Group Inc. Common Stock (Holding Company) (MDU) vs GeneDx Holdings Corp (WGS) Price & Performance

MDU Resources Group Inc. Common Stock (Holding Company)Trade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

MDU Resources Group Inc. Common Stock (Holding Company) vs GeneDx Holdings Corp — how do they compare? MDU Resources Group Inc. Common Stock (Holding Company) trades at $18.56 (market cap $3.92B), while GeneDx Holdings Corp trades at $68 (market cap $1.94B). The key difference: MDU Resources Group Inc. Common Stock (Holding Company) is far larger — about 2× GeneDx Holdings Corp's market cap, and MDU Resources Group Inc. Common Stock (Holding Company) pays a 3.03% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold MDU Resources Group Inc. Common Stock (Holding Company) for 0 Days and GeneDx Holdings Corp for 20 Days on average.

MDUWGS
Market Cap
$3.92B$1.94B
Volume
1,027,656524,385
Sector
UtilitiesHealth
52-Week High
$22.80$167.51
52-Week Low
$18.39$34.51
Typical Hold Time
0 Days20 Days
Enterprise Value
$6.45B$1.97B
Dividend Yield
3.03%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MDU Resources Group Inc. Common Stock (Holding Company)

No Aura AI signal available yet.

GeneDx Holdings Corp

GeneDx (WGS) trades at $64.96, up 1.79% today, showing mixed signals with bearish technical indicators but strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating expectations with record testing volumes, though profitability remains challenged with negative net margins. Recent news highlights product innovations and leadership recognition, while institutional interest grows with Dimensional Fund Advisors increasing its position by 143.4% in Q1 2026.

The stock presents a high-risk opportunity with 91% analyst buy ratings and an $81 consensus target offering 25% upside. However, significant fundamental challenges include negative profitability, high valuation multiples, and cash flow volatility. Investors should weigh strong growth potential in genomic testing against execution risks and competitive pressures in the healthcare technology sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MDU
100% Buy0% Sell
Avg holding period · 0 Days
WGS
100% Buy0% Sell
Avg holding period · 20 Days

About MDU Resources Group Inc. Common Stock (Holding Company)

MDU Resources Group, Inc. is a US holding company operating regulated electric and natural gas utility services alongside a construction materials and services business supplying asphalt, concrete, and aggregates.

Read more on MDU →

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS →